Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Impaired booster-induced SARS-CoV-2 antibody responses in rituximab-treated B-cell lymphoma patients despite peripheral B-Cell Recovery

Saved in:
Bibliographic Details
Published in:Radiology and Oncology
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1868552800999309312
collection WordPress RSS
FRELIP Feed Integration
container_title Radiology and Oncology
description
discipline_display Oncology
discipline_facet Oncology
format Online Article
RSS Article
genre Journal Article
id rss_article:61370
institution FRELIP
journal_source_facet Radiology and Oncology
last_indexed 2026-06-20T21:26:42.861Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Impaired booster-induced SARS-CoV-2 antibody responses in rituximab-treated B-cell lymphoma patients despite peripheral B-Cell Recovery
Oncology
General
Oncology
sub_discipline_display General
sub_discipline_facet General
subject_display Oncology
General
Oncology
subject_facet Oncology
General
Oncology
title Impaired booster-induced SARS-CoV-2 antibody responses in rituximab-treated B-cell lymphoma patients despite peripheral B-Cell Recovery
title_alt Respuestas de anticuerpos anti-SARS-CoV-2 inducidas por refuerzo deterioradas en pacientes con linfoma de células B tratados con rituximab a pesar de la recuperación de células B periféricas
Réponses anticorps anti-SARS-CoV-2 altérées après rappel chez les patients atteints de lymphome B traités par rituximab malgré une récupération des lymphocytes B périphériques
Respostas de anticorpos SARS-CoV-2 prejudicadas induzidas por reforço em pacientes com linfoma de células B tratados com rituximabe apesar da recuperação de células B periféricas
title_auth Impaired booster-induced SARS-CoV-2 antibody responses in rituximab-treated B-cell lymphoma patients despite peripheral B-Cell Recovery
title_es_txt Respuestas de anticuerpos anti-SARS-CoV-2 inducidas por refuerzo deterioradas en pacientes con linfoma de células B tratados con rituximab a pesar de la recuperación de células B periféricas
title_fr_txt Réponses anticorps anti-SARS-CoV-2 altérées après rappel chez les patients atteints de lymphome B traités par rituximab malgré une récupération des lymphocytes B périphériques
title_full Impaired booster-induced SARS-CoV-2 antibody responses in rituximab-treated B-cell lymphoma patients despite peripheral B-Cell Recovery
title_fullStr Impaired booster-induced SARS-CoV-2 antibody responses in rituximab-treated B-cell lymphoma patients despite peripheral B-Cell Recovery
title_full_unstemmed Impaired booster-induced SARS-CoV-2 antibody responses in rituximab-treated B-cell lymphoma patients despite peripheral B-Cell Recovery
title_pt_txt Respostas de anticorpos SARS-CoV-2 prejudicadas induzidas por reforço em pacientes com linfoma de células B tratados com rituximabe apesar da recuperação de células B periféricas
title_short Impaired booster-induced SARS-CoV-2 antibody responses in rituximab-treated B-cell lymphoma patients despite peripheral B-Cell Recovery
title_sort impaired booster-induced sars-cov-2 antibody responses in rituximab-treated b-cell lymphoma patients despite peripheral b-cell recovery
topic Oncology
General
Oncology
url https://sciendo.com/article/10.2478/raon-2026-0014